Solving for Chemotherapeutic Sensitivity: Adapting "Black Box" Methods to Study Patient-Derived Tumor Organoids

Ann Surg Oncol. 2022 Jan;29(1):4-6. doi: 10.1245/s10434-021-11003-z. Epub 2021 Oct 28.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents*
  • Humans
  • Neoplasms* / drug therapy
  • Organoids

Substances

  • Antineoplastic Agents